Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers – CLINICAL MICROBIOLOGY AND INFECTION

Polo, R; García-Albéniz, X; Terán, C; Morales, M; Rial-Crestelo, D; Garcinuño, MA; del Toro, MG; Hita, C; Gómez-Sirvent, JL; Buzón, L; de Santiago, AD; Arellano, JP; Sanz, J; Bachiller, P; Alfaro, EM; Díaz-Brito, V; Masiá, M; Hernández-Torres, A; Guerra, JM; Santos,...

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

Podzamczer, D; Mican, R; Tiraboschi, J; Portilla, J; Domingo, P; Llibre, JM; Ribera, E; Vivancos, MJ; Morano, L; Masia, M; Gomez, C; Fanjul, F; Payeras, A; Inciarte, A; Estrada, V; Rivero, A; Castro, A; Bernal, E; Vinuesa, D; Knobel, H; Troya, J; Macias, J; Montero,...